Scientific letters

• Hereditary transthyretin amyloidosis caused by p.Ser43Asn variant. A new endemic variant in Ecuador

  Elena Porres-López, Fernando de Frutos, Lorenzo Silva-Hernández, Lucía Galán, Esther González-López, Pablo García-Pavía

  Rev Esp Cardiol. 2023;76:564-6

• Fluid-dynamic impact of commissural alignment in transcatheter aortic valve implantation

  Ignacio J. Amat-Santos, José Sierra-Pallares, Alfredo Redondo, Sara Blasco-Turrión, Juan Pablo Sánchez-Luna, José Carlos González-Gutiérrez

  Rev Esp Cardiol. 2023;76:566-8

• Potential for controlled heart donation after circulatory determination of death

  Nerea Martínez-Franco, Eva Oliver-Juan, Jaume Tort, Laura Anguela-Calvet, Nicolás Manito-Lorite, Gabriel Moreno-González

  Rev Esp Cardiol. 2023;76:568-71

• Outflow tract ventricular tachycardia ablation from the axillary artery

  Cristina Lozano-Granero, Eduardo Franco, Roberto Matía-Francés, Antonio Hernández-Madrid, José Luis Zamorano, Javier Moreno

  Rev Esp Cardiol. 2023;76:571-3

• Clinical outcomes in heart transplant recipients with coronary abnormalities in the donor graft

  Pablo Fernández de-Aspe, Eduardo Barge-Caballero, Guillermo Aldama-López, Laura Fernández-Arias, José Manuel Vázquez-Rodríguez, María G. Crespo-Leiro

  Rev Esp Cardiol. 2023;76:473-4

• Transcatheter aortic valve implantation with the self-expandable and precrimped Vienna valve: first-in-man experience

  José Carlos González-Gutiérrez, Sara Blasco-Turrión, Alberto Campo-Prieto, Juan Pablo Sánchez-Luna, J. Alberto San Román, Ignacio J. Amat-Santos

  Rev Esp Cardiol. 2023;76:475-7

• CANDI study: chlorthalidone vs acetazolamide in patients with diuretic resistance in acute heart failure

  Paula Vela Martín, Andrea Matutano Muñoz, David Sánchez Ortiz, Fernando Domínguez, Ana Royuela, Marta Cobo Marcos

  Rev Esp Cardiol. 2023;76:477-80

• Treatment of mild asymptomatic cardiotoxicity in early-stage HER 2-positive breast cancer. Is it justified?

  Gerard Oristrell, Gemma Burcet, Filipa Valente, Santiago Escrivá-De-Romaní, Miriam Arumí, Ignacio Ferreira-González

  Rev Esp Cardiol. 2023;76:480-3

• Quality control of cardiovascular risk in hospitalized diabetic patients in cardiology services

  Javier Cuevas, Daniel Morena, Luis Gutiérrez, Pablo Flórez, Valentina Chiminazzo, Jesús María de la Hera

  Rev Esp Cardiol. 2023;76:483-5

• Initial experience with the coronary sinus reducer for the treatment of refractory angina in Spain

  Oriol Rodríguez-Leor, Santiago Jiménez Valero, Josep Gómez-Lara, Javier Escaned, Pablo Avanzas, Saleta Fernández, en representación de los investigadores del registro Re2-Cor

  Rev Esp Cardiol. 2023;76:381-3

• Early remote monitoring of pacemaker devices and benefits of this paradigm shift. The FAST REMOTE study

  Irene Valverde André, Mar González Vasserot, Beatriz Gonzalez Chana, Carlos González Matos, Lola Villagraz Tecedor, F. Javier García Fernández, en representación de los investigadores del estudio FAST REMOTE

  Rev Esp Cardiol. 2023;76:379-81

• Impact of the revised hemodynamic definition of pulmonary hypertension

  José Luis Callejas Rubio, Eduardo Moreno Escobar, Emilia Navascues Martínez, Pilar Martín de la Fuente, Teresa Gil Jiménez, Norberto Ortego Centeno

  Rev Esp Cardiol. 2023;76:383-4

• Third-degree atrioventricular block associated with the SARS-CoV-2 mRNA vaccine

  Alexandra Pons-Riverola, Pilar Mañas, Eduard Claver, Oona Meroño, Josep Comín-Colet, Ignasi Anguera

  Rev Esp Cardiol. 2023;76:384-6

• Usefulness of ambulatory milrinone perfusion in a cohort of advanced heart failure patients

  José María Viéitez Flórez, Francisco José Hernández Pérez, Cristina Mitroi, Sara Lozano Jiménez, Manuel Gómez Bueno, Javier Segovia Cubero

  Rev Esp Cardiol. 2023;76:386-8

• Transfemoral transcatheter tricuspid valve replacement with the Cardiovalve system

  Berenice Caneiro-Queija, Rodrigo Estévez-Loureiro, Miguel Piñón-Esteban, Manuel Barreiro-Pérez, José A. Baz-Alonso, Andrés Íñiguez-Romo

  Rev Esp Cardiol. 2023;76:270-2

• Age and stabilization of admissions for heart failure in Spain (2006-2019). The beginning of the end of the “epidemic”?

  María Anguita Gámez, Alberto Esteban Fernández, María García Márquez, Náyade del Prado, Francisco J. Elola Somoza, Manuel Anguita Sánchez

  Rev Esp Cardiol. 2023;76:272-4

• Twelve-month effect of a 2-month training program conducted in primary care for patients at cardiovascular risk

  Felícitas García-Ortún, Ángeles Jaén, Laura Solá, Lidia González-Gil, Amparo Alvarez Auñon, Alejandro de la Sierra

  Rev Esp Cardiol. 2023;76:274-6

• Impact on early patient mobilization of the use of a single vascular closure device in patients undergoing leadless pacemaker implantation

  Bieito Campos-García, Concepción Alonso-Martín, Zoraida Moreno-Weidmann, Enrique Rodríguez-Font, Francisco J. Méndez-Zurita, Xavier Viñolas

  Rev Esp Cardiol. 2023;76:276-8

• Association between in-hospital glycemic control and neurological outcome at 6 months of follow-up in survivors of out-of-hospital cardiac arrest

  Juan Carlos Valerio-Rojas, Marc Izquierdo, Oriol de Diego, Emilio Ortega, Ignacio Conget, Rut Andrea

  Rev Esp Cardiol. 2023;76:278-80

• Suboptimal anticoagulation with vitamin K antagonists: the need to change the national therapeutic positioning report

  Ana Ledo Piñeiro, Sergio Raposeiras-Roubín, Emad Abu-Assi, Pablo Domínguez Erquicia, Inmaculada González Bermúdez, Andrés Íñiguez Romo

  Rev Esp Cardiol. 2023;76:197-8